Dr. Anilkumar Mannava

Dr. Anilkumar Mannava

Consultant Gastroenterologist & Hepatologist
13+ Years of Experience

Dr. Anilkumar Mannava is a highly experienced Consultant Gastroenterologist and Hepatologist known for his patient-centered approach and clinical expertise. With over 13 years of practice in the field, he is dedicated to diagnosing complex gastrointestinal and liver disorders while focusing on improving the overall quality of life for his patients.

He has also made significant contributions to clinical research as a principal investigator in gastrointestinal studies and has co-led randomized clinical trials for drug therapies in hepatitis.

Educational Qualifications

  • DNB (Gastroenterology)
    Global Hospital, Lakdikapul, Hyderabad

  • MD (General Medicine)
    Sri Devaraj Urs Medical College, Kolar, Karnataka

  • MBBS
    Dr. Pinnamaneni Siddhartha Institute of Medical Sciences & Research Foundation, Vijayawada, Andhra Pradesh (Affiliated to NTR University of Health Sciences)

Dr. Anilkumar Mannava
MD (General Medicine), DNB (Gastroenterology)

Department: Gastroenterology
Exp: 13 yrs
Designation: Consultant Gastroenterologist and Hepatologist
Languages: Telugu, Kannada, English, Hindi
Med Reg No: 66711
Location: Secunderabad

Professional Experience

2020 – Present: Consultant Gastroenterologist & Hepatologist
2019: Consultant Gastroenterologist Global Hospital, Lakdikapul, Hyderabad
2015 – 2016: Senior Resident, General Medicine KMC, Mangalore
2014 – 2015: Senior Resident, General Medicine KMC, Manipal
2011 – 2014: Junior Resident, General Medicine Sri Devaraj Urs Medical College, Kolar

Core Services

Therapeutic Endoscopy & Colonoscopy Therapeutic ERCP Spyglass Cholangioscopy Interventional Biliary & Pancreatico EUS Peroral Endoscopic Myotomy (POEM) Third Space Endoscopy Endoscopic Mucosal Resection (EMR) Endoscopic Mucosal Dissection (ESD)

Areas of Special Interest & Expertise

Advanced Therapeutic Endoscopy ERCP & EUS Third Space Endoscopy Techniques Endoscopic Bariatric Procedures Clinical Research in Gastroenterology & Hepatology

Research & Publications

  • Prevalence of Functional Dyspepsia in a Rural Medical College Hospital – Published in Journal of Evolution of Medical and Dental Sciences, 2014

  • Jaundice Evaluation in Medical Wards – Published in Journal of Biological and Scientific Opinion, 2014

  • Acute Methemoglobinemia Due to Nitrobenzene Poisoning: Case Series – Published in International Journal of Medical Research & Health Sciences, 2014

  • A Rare Case of Snake Bite with Severe Isolated Hematotoxicity – Published in Journal of Clinical and Biomedical Sciences, 2011

  • Prevalence of Functional Dyspepsia – Presented at KAPICON 2012, Hassan

  • ICU Admission Characteristics and Outcomes in Elderly Patients – Presented at KAPICON 2013, Mangalore

  • Correlation of Insulin Resistance and Dyslipidemia in NAFLD – Presented at KRSSDI 2014, Belgaum

  • SNPs in PNPLA3, APOC3 and TM6SF2 Genes in NAFLD – Presented at APDW 2019, Kolkata

  • Sudden Sensorineural Hearing Loss in Type 1 Diabetes with DKA – Presented at KAPICON 2012, Hassan

  • Jaundice Evaluation in Medical Wards – Presented at APICON 2013, Coimbatore

  • Management of a Patient Waitlisted for Liver Transplant – Published in ISGCON Yearbook, 2017

  • Beta Blockers in Cirrhosis of Liver – Published in Gastroenterology Update, ISG, 2018

  • Acute Liver Failure – Published in Clinical Gastroenterology, 4th Ed., Paras Medical Publisher, 2020

  • Renal Dysfunction in Chronic Liver Disease – Published in Clinical Gastroenterology, 4th Ed., Paras Medical Publisher, 2020

  • Phase IV Study: Sofosbuvir/Daclatasvir in Genotype 3 HCV – Protocol ID: MYL-MHD-4001

  • Phase 3 Study: Selonsertib in Compensated Cirrhosis (NASH) – Protocol ID: GS-US-384-1944

  • Phase 3 Study: Selonsertib in NASH with Bridging Fibrosis – Protocol ID: GS-US-384-1943

  • Phase IV Study: MyHep LVIR™ & MyDekla™ in HCV Genotype 1 & 3 – Protocol ID: MYL-SLD-4001

  • Phase IV Study: MyHep All™ in Chronic HCV – Protocol ID: MYL-MYV-4001

  • Phase 3 Study: Tenofovir Alafenamide vs TDF in Chronic Hepatitis B – Protocol ID: GS-US-320-0110

  • Post-Marketing Study: Sofosbuvir-Based Regimens in HCV – Protocol ID: GS-US-334-1775

  • Phase 3 Study: Sofosbuvir/Velpatasvir in Chronic HCV – Protocol ID: GS-US-342-1521